These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy of low dose purified FSH in ovulation induction following pituitary desensitization in polycystic ovarian syndrome. Buckler HM; Critchley HO; Cantrill JA; Shalet SM; Anderson DC; Robertson WR Clin Endocrinol (Oxf); 1993 Feb; 38(2):209-17. PubMed ID: 8435902 [TBL] [Abstract][Full Text] [Related]
3. Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease. Lanzone A; Fulghesu AM; Spina MA; Apa R; Menini E; Caruso A; Mancuso S J Clin Endocrinol Metab; 1987 Dec; 65(6):1253-8. PubMed ID: 3119655 [TBL] [Abstract][Full Text] [Related]
4. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial. Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878 [TBL] [Abstract][Full Text] [Related]
5. Low-dose follicle stimulating hormone for ovulation induction in polycystic ovary syndrome. Strowitzki T; Seehaus D; Korell M; Hepp H J Reprod Med; 1994 Jul; 39(7):499-503. PubMed ID: 7966037 [TBL] [Abstract][Full Text] [Related]
6. Ovulation induction with low doses of "pure" follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease. Bregieiro LO; de Moura MD; Ferriani RA; Bailão LA; de Sá MF Int J Fertil Menopausal Stud; 1993; 38(3):152-9. PubMed ID: 8348163 [TBL] [Abstract][Full Text] [Related]
7. Low-dose ovulation induction with urinary gonadotropins or recombinant follicle stimulating hormone in patients with polycystic ovary syndrome. Szilágyi A; Bártfai G; Mánfai A; Koloszár S; Pál A; Szabó I Gynecol Endocrinol; 2004 Jan; 18(1):17-22. PubMed ID: 15106360 [TBL] [Abstract][Full Text] [Related]
8. Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone. Shoham Z; Patel A; Jacobs HS Fertil Steril; 1991 Jun; 55(6):1051-6. PubMed ID: 1903725 [TBL] [Abstract][Full Text] [Related]
9. Comparison of intermediate-dose purified urinary follicle-stimulating hormone with and without human chorionic gonadotropin for ovulation induction in polycystic ovarian disease. Claman P; Seibel MM; McArdle C; Berger MJ; Taymor ML Fertil Steril; 1986 Sep; 46(3):518-21. PubMed ID: 3091412 [TBL] [Abstract][Full Text] [Related]
10. Induction of ovulation by intermittent intravenous purified follicle-stimulating hormone in polycystic ovarian disease. Lanzone A; Fulghesu AM; Conte M; Apa R; Caruso A; Mancuso S Fertil Steril; 1987 Dec; 48(6):1058-61. PubMed ID: 3119371 [TBL] [Abstract][Full Text] [Related]
11. Treatment of clomiphene citrate-resistant polycystic ovarian syndrome with pure follicle-stimulating hormone or human menopausal gonadotropin. McFaul PB; Traub AI; Thompson W Fertil Steril; 1990 May; 53(5):792-7. PubMed ID: 2110070 [TBL] [Abstract][Full Text] [Related]
12. Ovulation induction by step-down administration of purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome. Mizunuma H; Takagi T; Yamada K; Andoh K; Ibuki Y; Igarashi M Fertil Steril; 1991 Jun; 55(6):1195-6. PubMed ID: 1903734 [TBL] [Abstract][Full Text] [Related]
13. Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment. Fulghesu AM; Apa R; Belosi C; Ciampelli M; Selvaggi L; Cucinelli F; Caruso A; Mancuso S; Lanzone A Horm Res; 2001; 55(5):224-8. PubMed ID: 11740143 [TBL] [Abstract][Full Text] [Related]
14. Ovulation induction with low-dose follicle-stimulating hormone in women with the polycystic ovary syndrome. Dale O; Tanbo T; Lunde O; Abyholm T Acta Obstet Gynecol Scand; 1993 Jan; 72(1):43-6. PubMed ID: 8382432 [TBL] [Abstract][Full Text] [Related]
15. Responses of polycystic ovarian syndrome and related variants to low-dose follicle stimulating hormone. Yong EL; Ng SC; Chan C; Kumar J; Teo LS; Ratnam S Int J Gynaecol Obstet; 1997 Jun; 57(3):305-11. PubMed ID: 9215494 [TBL] [Abstract][Full Text] [Related]
16. Daily or alternate-day FSH therapy in patients with polycystic ovarian disease resistant to clomiphene citrate treatment. McFaul PB; Traub AI; Sheridan B; Leslie H Int J Fertil; 1989; 34(3):194-8. PubMed ID: 2567714 [TBL] [Abstract][Full Text] [Related]
17. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. Homburg R; Howles CM Hum Reprod Update; 1999; 5(5):493-9. PubMed ID: 10582786 [TBL] [Abstract][Full Text] [Related]
18. A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome. Homburg R; Levy T; Ben-Rafael Z Fertil Steril; 1995 Apr; 63(4):729-33. PubMed ID: 7890055 [TBL] [Abstract][Full Text] [Related]
19. Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy. Orvieto R; Homburg R Fertil Steril; 2009 Apr; 91(4 Suppl):1533-5. PubMed ID: 18990384 [TBL] [Abstract][Full Text] [Related]
20. Low-dose FSH stimulation in polycystic ovary syndrome: comparison of 3 FSH-preparations. Strowitzki T; Seehaus D; Korell M; Hepp H Exp Clin Endocrinol Diabetes; 1998; 106(5):435-9. PubMed ID: 9831312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]